After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, NVAX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Novavax, Inc is $1.31B. A total of 2.82 million shares were traded on the day, compared to an average of 4.21M shares.
In the most recent transaction, King Rachel K. sold 4,150 shares of NVAX for 9.02 per share on Dec 13 ’24. After the transaction, the Director now owns 14,770 company shares. In a previous transaction on Dec 31 ’24, YOUNG JAMES F sold 5,400 shares at 8.00 per share. NVAX shares that Director owns now total 51,760.
Among the insiders who sold shares, YOUNG JAMES F disposed of 4,600 shares on Dec 24 ’24 at a per-share price of $8.48. This resulted in the Director holding 57,160 shares of NVAX after the transaction. In another insider transaction, YOUNG JAMES F bought 10,000 shares at $8.48 per share on Dec 24 ’24.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NVAX has a high of $23.86 and a low of $3.81.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NVAX’s latest balance sheet shows that the firm has $1.52B in Cash & Short Term Investments as of fiscal 2021. There were $453.99M in debt and $2.39B in liabilities at the time. Its Book Value Per Share was -$3.29, while its Total Shareholder’s Equity was -$351.67M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVAX is Buy with a score of 3.67.
